SeekingAlpha · Sep 4, 2026
Nature's Sunshine Products: Why Zero Debt And Cash Reserves Make It A Buy
Natureâs Sunshine (NATR) rated Buy with $18 target (27% upside).
NASDAQ · NATR
Consumer Defensive · Packaged Foods
$13.55
Down-$0.06 (-0.44%)
Updated Sep 13, 2026, 4:04 PM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 19 trading sessions · Daily adjusted prices
NATR closed at $13.55 after 19 trading sessions, down 7.82% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $13.67 | $13.83 | $13.45 | $13.55 | 123.02K |
| Sep 10, 2026 | $13.65 | $13.94 | $13.515 | $13.61 | 138.89K |
| Sep 9, 2026 | $13.67 | $13.78 | $13.50 | $13.66 | 171.58K |
| Sep 8, 2026 | $14.00 | $14.17 | $13.65 | $13.82 | 148.22K |
| Sep 4, 2026 | $13.90 | $14.07 | $13.865 | $14.02 | 92.99K |
| Sep 3, 2026 | $14.21 | $14.21 | $13.73 | $13.80 | 120.56K |
| Sep 2, 2026 | $13.90 | $14.28 | $13.895 | $14.16 | 160.4K |
| Sep 1, 2026 | $14.09 | $14.35 | $13.82 | $13.87 | 216.87K |
| Aug 31, 2026 | $14.20 | $14.26 | $13.945 | $14.15 | 257.06K |
| Aug 28, 2026 | $14.02 | $14.30 | $13.98 | $14.21 | 240.64K |
| Aug 27, 2026 | $14.13 | $14.18 | $13.72 | $13.92 | 284.79K |
| Aug 26, 2026 | $14.19 | $14.46 | $14.19 | $14.29 | 199.74K |
| Aug 25, 2026 | $14.28 | $14.40 | $14.04 | $14.19 | 256.3K |
| Aug 24, 2026 | $14.38 | $14.7199 | $14.29 | $14.30 | 192.79K |
| Aug 21, 2026 | $14.40 | $14.45 | $14.16 | $14.34 | 249.78K |
| Aug 20, 2026 | $14.59 | $14.89 | $14.19 | $14.32 | 207.32K |
| Aug 19, 2026 | $14.70 | $15.04 | $14.51 | $14.56 | 150.98K |
| Aug 18, 2026 | $14.68 | $14.975 | $14.57 | $14.65 | 200.97K |
| Aug 17, 2026 | $15.05 | $15.05 | $14.63 | $14.70 | 263.46K |
The latest Smart Investors Daily articles mentioning NATR.
NATR research
Company profile and research snapshot.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 10, 2026 | DA Davidson | Buy | — |
| Jul 30, 2026 | Canaccord Genuity | Buy | — |
| May 11, 2026 | DA Davidson | Buy | — |
| Mar 12, 2026 | DA Davidson | Buy | — |
| Mar 11, 2026 | Canaccord Genuity | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Sep 4, 2026
Natureâs Sunshine (NATR) rated Buy with $18 target (27% upside).
SeekingAlpha · Sep 3, 2026
Nature's Sunshine Products is upgraded to Strong Buy despite a 47.9% stock decline and reduced 2026 guidance. Read more on NATR stock here.
Yahoo · Sep 3, 2026
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Yahoo · Sep 2, 2026
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning NATR.